PortfoliosLab logoPortfoliosLab logo
ADMA vs. MOD
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

ADMA vs. MOD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ADMA Biologics, Inc. (ADMA) and Modine Manufacturing Company (MOD). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

ADMA vs. MOD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ADMA
ADMA Biologics, Inc.
-50.60%6.36%279.42%16.49%175.18%-27.69%-51.25%67.36%-25.55%-37.30%
MOD
Modine Manufacturing Company
62.32%15.16%94.19%200.60%96.83%-19.67%63.12%-28.77%-46.49%35.57%

Fundamentals

Market Cap

ADMA:

$2.20B

MOD:

$11.44B

EPS

ADMA:

$0.60

MOD:

$1.83

PE Ratio

ADMA:

15.07

MOD:

118.40

PS Ratio

ADMA:

4.34

MOD:

4.03

PB Ratio

ADMA:

4.60

MOD:

10.13

Total Revenue (TTM)

ADMA:

$510.17M

MOD:

$2.87B

Gross Profit (TTM)

ADMA:

$292.77M

MOD:

$684.00M

EBITDA (TTM)

ADMA:

$195.35M

MOD:

$264.30M

Returns By Period

In the year-to-date period, ADMA achieves a -50.60% return, which is significantly lower than MOD's 62.32% return. Over the past 10 years, ADMA has underperformed MOD with an annualized return of 0.68%, while MOD has yielded a comparatively higher 34.74% annualized return.


ADMA

1D
-1.53%
1M
-42.13%
YTD
-50.60%
6M
-38.54%
1Y
-54.59%
3Y*
39.63%
5Y*
37.55%
10Y*
0.68%

MOD

1D
7.19%
1M
-4.64%
YTD
62.32%
6M
52.44%
1Y
182.36%
3Y*
111.06%
5Y*
70.32%
10Y*
34.74%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ADMA vs. MOD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADMA
ADMA Risk / Return Rank: 77
Overall Rank
ADMA Sharpe Ratio Rank: 55
Sharpe Ratio Rank
ADMA Sortino Ratio Rank: 77
Sortino Ratio Rank
ADMA Omega Ratio Rank: 77
Omega Ratio Rank
ADMA Calmar Ratio Rank: 1111
Calmar Ratio Rank
ADMA Martin Ratio Rank: 33
Martin Ratio Rank

MOD
MOD Risk / Return Rank: 9494
Overall Rank
MOD Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
MOD Sortino Ratio Rank: 9191
Sortino Ratio Rank
MOD Omega Ratio Rank: 9292
Omega Ratio Rank
MOD Calmar Ratio Rank: 9696
Calmar Ratio Rank
MOD Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ADMA vs. MOD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and Modine Manufacturing Company (MOD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ADMAMODDifference

Sharpe ratio

Return per unit of total volatility

-0.95

2.72

-3.68

Sortino ratio

Return per unit of downside risk

-1.39

2.94

-4.33

Omega ratio

Gain probability vs. loss probability

0.82

1.41

-0.59

Calmar ratio

Return relative to maximum drawdown

-0.84

6.30

-7.13

Martin ratio

Return relative to average drawdown

-1.86

16.81

-18.67

ADMA vs. MOD - Sharpe Ratio Comparison

The current ADMA Sharpe Ratio is -0.95, which is lower than the MOD Sharpe Ratio of 2.72. The chart below compares the historical Sharpe Ratios of ADMA and MOD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ADMAMODDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.95

2.72

-3.68

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.63

1.20

-0.57

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.01

0.60

-0.59

Sharpe Ratio (All Time)

Calculated using the full available price history

0.01

0.20

-0.20

Correlation

The correlation between ADMA and MOD is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

ADMA vs. MOD - Dividend Comparison

Neither ADMA nor MOD has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ADMA vs. MOD - Drawdown Comparison

The maximum ADMA drawdown since its inception was -91.28%, smaller than the maximum MOD drawdown of -97.53%. Use the drawdown chart below to compare losses from any high point for ADMA and MOD.


Loading graphics...

Drawdown Indicators


ADMAMODDifference

Max Drawdown

Largest peak-to-trough decline

-91.28%

-97.53%

+6.25%

Max Drawdown (1Y)

Largest decline over 1 year

-66.18%

-27.55%

-38.63%

Max Drawdown (5Y)

Largest decline over 5 years

-66.18%

-57.47%

-8.71%

Max Drawdown (10Y)

Largest decline over 10 years

-87.33%

-88.13%

+0.80%

Current Drawdown

Current decline from peak

-63.24%

-9.14%

-54.10%

Average Drawdown

Average peak-to-trough decline

-52.91%

-37.84%

-15.07%

Ulcer Index

Depth and duration of drawdowns from previous peaks

29.86%

10.32%

+19.54%

Volatility

ADMA vs. MOD - Volatility Comparison

ADMA Biologics, Inc. (ADMA) has a higher volatility of 31.94% compared to Modine Manufacturing Company (MOD) at 24.72%. This indicates that ADMA's price experiences larger fluctuations and is considered to be riskier than MOD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ADMAMODDifference

Volatility (1M)

Calculated over the trailing 1-month period

31.94%

24.72%

+7.22%

Volatility (6M)

Calculated over the trailing 6-month period

44.54%

49.88%

-5.34%

Volatility (1Y)

Calculated over the trailing 1-year period

57.47%

67.49%

-10.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

60.00%

59.11%

+0.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

69.12%

58.16%

+10.96%

Financials

ADMA vs. MOD - Financials Comparison

This section allows you to compare key financial metrics between ADMA Biologics, Inc. and Modine Manufacturing Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
139.16M
805.00M
(ADMA) Total Revenue
(MOD) Total Revenue
Values in USD except per share items

ADMA vs. MOD - Profitability Comparison

The chart below illustrates the profitability comparison between ADMA Biologics, Inc. and Modine Manufacturing Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
63.8%
23.1%
Portfolio components
ADMA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, ADMA Biologics, Inc. reported a gross profit of 88.82M and revenue of 139.16M. Therefore, the gross margin over that period was 63.8%.

MOD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Modine Manufacturing Company reported a gross profit of 186.10M and revenue of 805.00M. Therefore, the gross margin over that period was 23.1%.

ADMA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, ADMA Biologics, Inc. reported an operating income of 62.75M and revenue of 139.16M, resulting in an operating margin of 45.1%.

MOD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Modine Manufacturing Company reported an operating income of 96.80M and revenue of 805.00M, resulting in an operating margin of 12.0%.

ADMA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, ADMA Biologics, Inc. reported a net income of 49.38M and revenue of 139.16M, resulting in a net margin of 35.5%.

MOD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Modine Manufacturing Company reported a net income of -47.40M and revenue of 805.00M, resulting in a net margin of -5.9%.